Nkarta, Inc.
NKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787400
No open-market purchases or sales by Nkarta, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Nkarta, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 89
- −8 vs. Q1 2021
- Shares held
- 24.1M
- −2.17M (−8.2%) vs. Q1 2021
- Total value
- $764.7M
- −$102.1M (−11.8%) vs. Q1 2021
- New holders
- 16
- 23 more added
- Sold out
- 24
- 33 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 126 | $121.6M |
| Q4 2025 | 119 | $103.2M |
| Q3 2025 | 120 | $119.4M |
| Q2 2025 | 104 | $96.9M |
| Q1 2025 | 111 | $113.2M |
| Q4 2024 | 112 | $154.8M |
| Q3 2024 | 119 | $301.7M |
| Q2 2024 | 112 | $391.5M |
| Q1 2024 | 115 | $687.1M |
| Q4 2023 | 94 | $270.2M |
| Q3 2023 | 85 | $50.7M |
| Q2 2023 | 97 | $86.5M |
| Q1 2023 | 100 | $147.0M |
| Q4 2022 | 121 | $251.9M |
| Q3 2022 | 105 | $561.5M |
| Q2 2022 | 115 | $536.7M |
| Q1 2022 | 84 | $287.2M |
| Q4 2021 | 92 | $366.5M |
| Q3 2021 | 87 | $651.4M |
| Q2 2021 | 89 | $764.7M |
| Q1 2021 | 97 | $866.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Nkarta, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Voya Investment Management LLC | 0 | $0 | 0.00% | −8,838−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −8,099−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −7,919−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −7,730−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −7,181−100.0% | Sold out |
| Alpha Paradigm Partners, LLC | 0 | $0 | 0.00% | −7,029−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −6,669−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,429−100.0% | Sold out |
| First Mercantile Trust Co | 0 | $0 | 0.00% | −1,055−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −816−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −616−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −158−100.0% | Sold out |